Annual Drug Patent Expirations for ZOMIG Zomig is a drug marketed by Astrazeneca and IPR and is included in three NDAs. It is available from one supplier. There are two…
The post New patent expiration for Astrazeneca drug ZOMIG appeared first on DrugPa…
New patent expiration for Astrazeneca drug ZOMIG Read Post »
ZOMIG (zolmitriptan) Astrazeneca Patent: 7,220,767 Expiration: May 28, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug …
Drug Patent Expirations for the Week of May 23, 2021 Read Post »
ZOMIG (zolmitriptan) Astrazeneca Patent: 7,220,767 Expiration: May 28, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug …
Drug Patent Expirations for the Week of May 23, 2021 Read Post »
Annual Drug Patent Expirations for NICODERM+CQ Nicoderm Cq is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There is…
The post New patent expiration for Sanofi Aventis drug NICODERM CQ appeared firs…
New patent expiration for Sanofi Aventis drug NICODERM CQ Read Post »
Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from four suppliers. There are ten…
The post New patent expiration for Sucampo Pharma drug AMITIZA appeared first on…
New patent expiration for Sucampo Pharma drug AMITIZA Read Post »
Annual Drug Patent Expirations for FIRMAGON Firmagon is a drug marketed by Ferring and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Ferring drug FIRMAGON appeared first…
TECHNIVIE (ombitasvir; paritaprevir; ritonavir) Abbvie inc Patent: 7,364,752 Expiration: May 10, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Ex…
Drug Patent Expirations for the Week of May 9, 2021 Read Post »
Annual Drug Patent Expirations for ORAVERSE Oraverse is a drug marketed by Septodont Holding and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Septodont Holding drug ORAVERSE appea…
New patent expiration for Septodont Holding drug ORAVERSE Read Post »
Annual Drug Patent Expirations for SUSTOL Sustol is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Heron Theraps drug SUSTOL appeared first on Drug…
New patent expiration for Heron Theraps drug SUSTOL Read Post »
Annual Drug Patent Expirations for TECHNIVIE Technivie is a drug marketed by Abbvie Inc and is included in one NDA. There are nine patents protecting this drug. Drug patent litigation…
The post New patent expiration for Abbvie Inc drug TECHNIVIE appear…
New patent expiration for Abbvie Inc drug TECHNIVIE Read Post »